TERRY KRANTZ: Open Payments
NPI 1700846342 · CAMDENTON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$306 in 15 payments from 9 companies in 2025. Trend: 2023 $289 · 2024 $257 · 2025 $306
Food & beverage: $306
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 6 | $139 |
| ABBVIE INC. | 2 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Lilly USA, LLC | 1 | $21 |
| Boston Scientific Corporation | 1 | $20 |
| PFIZER INC. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Amgen Inc. | 1 | $15 |
| Lundbeck LLC | 1 | $15 |
Products named: INGREZZA, VRAYLAR, REXULTI, CAPLYTA, MOUNJARO, Axonics, PREVNAR 20, OTEZLA.
Industry payments across MO — which companies pay providers there.
